Acknowledgement
Supported by : Chulabhorn Hospital
References
- Bieze M, Klumpen HJ, Verheij J, et al (2014). Diagnostic accuracy of (18) F-methylcholine positron emission tomography/computed tomography for intra- and extrahepatic hepatocellular carcinoma. Hepatol, 59, 996-1006. https://doi.org/10.1002/hep.26781
- Bolog N, Andreisek G, Oancea I, et al (2011). CT and MR imaging of hepatocellular carcinoma. J Gastrointestin Liver Dis, 20, 181-9.
- Bruix J, Sherman M, Practice Guidelines Committee AAftSoLD (2005). Management of hepatocellular carcinoma. Hepatol, 42, 1208-36. https://doi.org/10.1002/hep.20933
- Castilla-Lievre MA, Franco D, Gervais P, et al (2016). Diagnostic value of combining C-choline and F-FDG PET/CT in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging, 43, 852-9. https://doi.org/10.1007/s00259-015-3241-0
- Fartoux L, Balogova S, Nataf V, et al (2012). A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection. Nucl Med Commun, 33, 757-65. https://doi.org/10.1097/MNM.0b013e328350fb9f
- Glunde K, Bhujwalla ZM, Ronen SM (2011). Choline metabolism in malignant transformation. Nat Rev Cancer, 11, 835-48. https://doi.org/10.1038/nrc3162
- Hara T, Kosaka N, Shinoura N, et al (1997). PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med, 38, 842-7.
- Iwata Y, Shiomi S, Sasaki N, et al (2000). Clinical usefulness of positron emission tomography with fluorine-18- fluorodeoxyglucose in the diagnosis of liver tumors. Ann Nucl Med, 14, 121-6. https://doi.org/10.1007/BF02988591
- Jeng LB, Changlai SP, Shen YY, et al (2003). Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers. Hepatogastroenterol, 50, 2154-6.
- Kanwal F, Befeler A, Chari RS, et al (2012). Potentially curative treatment in patients with hepatocellular cancer--results from the liver cancer research network. Aliment Pharmacol Ther, 36, 257-65. https://doi.org/10.1111/j.1365-2036.2012.05174.x
- Kelloff GJ, Hoffman JM, Johnson B, et al (2005). Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res, 11, 2785-808. https://doi.org/10.1158/1078-0432.CCR-04-2626
- Khan MA, Combs CS, Brunt EM, et al (2000). Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol, 32, 792-7.
- Kolthammer JA, Corn DJ, Tenley N, et al (2011). PET imaging of hepatocellular carcinoma with 18F-fluoroethylcholine and 11C-choline. Eur J Nucl Med Mol Imaging, 38, 1248-56. https://doi.org/10.1007/s00259-011-1743-y
- Kuang Y, Salem N, Corn DJ, et al (2010). Transport and metabolism of radiolabeled choline in hepatocellular carcinoma. Mol Pharm, 7, 2077-92. https://doi.org/10.1021/mp1001922
- Lin WY, Tsai SC, Hung GU (2005). Value of delayed 18F-FDGPET imaging in the detection of hepatocellular carcinoma. Nucl Med Commun, 26, 315-21. https://doi.org/10.1097/00006231-200504000-00003
- Lopci E, Torzilli G, Poretti D, et al (2015). Diagnostic accuracy of (1)(1)C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma. Eur J Nucl Med Mol Imaging, 42, 1399-407. https://doi.org/10.1007/s00259-015-3079-5
- Picchio M, Castellucci P (2012). Clinical indications of C-choline PET/CT in prostate cancer patients with biochemical relapse. Theranostics, 2, 313-7. https://doi.org/10.7150/thno.4007
- Talbot JN, Fartoux L, Balogova S, et al (2010). Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease. J Nucl Med, 51, 1699-706. https://doi.org/10.2967/jnumed.110.075507
- Talbot JN, Gutman F, Fartoux L, et al (2006). PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging, 33, 1285-9. https://doi.org/10.1007/s00259-006-0164-9
- Teefey SA, Hildeboldt CC, Dehdashti F, et al (2003). Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiol, 226, 533-42. https://doi.org/10.1148/radiol.2262011980
- Wolfort RM, Papillion PW, Turnage RH, et al (2010). Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Int Surg, 95, 67-75.
- Wu HB, Wang QS, Li BY, et al (2011). F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma. Clin Nucl Med, 36, 1092-7. https://doi.org/10.1097/RLU.0b013e3182335df4
- Yamamoto Y, Nishiyama Y, Kameyama R, et al (2008). Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET. J Nucl Med, 49, 1245-8. https://doi.org/10.2967/jnumed.108.052639